Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.
Demographics, Characteristics of Youth Receiving Migraine Treatment at Infusion Center
April 27th 2019A retrospective chart review examining demographic characteristics of children and adolescents receiving infusions at an outpatient center for prolonged headache found that their migraines were more disabling and resulted in lower quality of life than those who did not seek treatment at a center.
The Potential of NLP to Diagnose Childhood Asthma Earlier, Improve Future Outcomes
April 25th 2019Using a form of artificial intelligence called natural language processing (NLP) to mine information in electronic health records (EHRs) can uncover early cases of childhood asthma more quickly, reducing the long-term morbidity of this chronic disease, improve current care, and streamline and advance new therapeutic discoveries.
HHS Announces 5 New Primary Care Payment Models to Encourage Value-Based Care
April 22nd 2019At the American Medical Association headquarters Monday, HHS Secretary Alex Azar and CMS Administrator Seema Verma announced 5 new Medicare primary care payment models designed to eventually incentivize the entire healthcare system to transition to value-based care, particulary for patients with chronic conditions.
Splenectomy Before Stem Cell Transplant May Help Certain Patients With MF
April 20th 2019Splenectomy before allogeneic hematopoietic stem cell transplantation (alloHSCT) might be a promising option in patients with myelofibrosis (MF) who failed to achieve significant spleen response after ruxolitinib therapy, according to results from a recently published study.
Four States Picked for $350 Million Study to Prevent, Treat OUD
April 19th 2019Locations in Ohio, Kentucky, New York, and Massachusetts were selected for an opioid abuse prevention and treatment initiatives as part of a multimillion dollar interagency federal research effort, led by the National Institutes of Health.
Bill Seeks to Ban Online Sales of e-Cigarettes, Raise Age to Buy Tobacco to 21
April 17th 2019Two Democratic members of Congress introduced a bill this week aimed at reversing the increase in vaping among children and teenagers by raising the minimum purchasing age for all tobacco products to 21 years old, among other things.
As Comorbidities Pile Up, True Diabetes Cost Measured by More Than Insulin, Panel Says
April 14th 2019For endocrinologists, a cardiologist, a diabetes educator, and a room full of fellow health workers, the cost of doing nothing—not just to treat diabetes, but also to prevent it— is what feeds into the exorbitant cost of the disease, according to presentations and a panel at the inaugural meeting of the Institute for Value Based Medicine (IVBM) in Diabetes, an initiative of The American Journal of Managed Care®.
Traffic-Related Pollution Linked to New Pediatric Asthma Cases Every Year
April 11th 2019The United States ranks highly in a global study examining traffic-related pollution and new cases of childhood asthma, and the authors suggest that pollution guidelines may need to be re-evaluated, since most affected children live in areas where pollution falls within current limits.
PBM Executives Tout Value Before Senate Finance Committee
April 10th 2019Pharmacy benefit manager executives told members of the Senate Finance Committee that rebates are not the cause of high drug prices, and that more must be done to end evergreening and pay-for-delay tactics. Senators were skeptical.
Oncologists, Hematologists Welcome CDC Clarification on Opioid Therapy for Chronic Pain
April 9th 2019Oncologists and hematologists are welcoming a clarification from the CDC about the use of opioid pain relief for patients with cancer, past cancer, or sickle cell disease, and they are hopeful that payers see the update so that patients in pain are not denied or delayed relief.
Cigna, Express Scripts Capping Insulin Co-Pays at $25 for Participating Commercial Members
April 3rd 2019Cigna and its pharmacy benefit manager Express Scripts said they are launching a program for patients with diabetes in its commercial plans so that they pay no more than $25 for a 30-day supply of insulin.
Review Reaffirms Beta-Blockers for Migraine Prevention
April 1st 2019A recent literature review assessed the efficacy of beta-blockers to prevent migraine and tension headache. It found that propranolol worked better than placebo for episodic migraine headaches, but the evidence for efficacy in tension headaches was limited.
Researchers Develop Targeted Next-Generation Sequencing Assay for Myeloid Neoplasms
March 30th 2019Researchers from South Korea said they have developed a next-generation sequencing (NGS) assay to detect somatic mutations, translocations, and germline mutations in a single assay for the purpose of supplementing or replacing conventional tests in patients with myeloid neoplasms.
Predicting Responders to ICB Therapy in Advanced Melanoma
March 29th 2019Recent work looking at the response to immune checkpoint blockade (ICB) therapy given before surgery for advanced melanoma found increased infiltration of B cells, a type of white blood cell, in patients who responded to therapy compared with those who did not.
Judge Rules Trump's DOL Tried to Create "End Run" Around ACA With Association Health Plans
March 29th 2019Another federal district court judge has handed the Trump administration a major defeat this week in its attempts to redo rules about US health insurance, saying that its efforts to expand association health plans (AHPs) were “clearly an end-run” around the Affordable Care Act (ACA).
UK Patients, Physicians Feel More Burdened by Myeloproliferative Neoplasms
March 22nd 2019A recent study found that patients with myeloproliferative neoplasms living in the United Kingdom, as well as their doctors, felt more burdened by the disease than other patients and providers in other parts of the world.